50
Views
25
CrossRef citations to date
0
Altmetric
Review

Being stoned: a review of self-reported cannabis effects

, &
Pages 453-460 | Received 20 Feb 2002, Accepted 27 Jun 2003, Published online: 12 Jul 2009

References

  • Costa e Silva JA. Evidence-based analysis of the worldwide abuse of licit and illicit drugs. Hum Psychopharmacol 2002;17:131–40.
  • Substance Abuse and Mental Health Services Administra- tion. Summary of Findings from the 2000 National Household Survey on Drug Abuse. Rockville, MD: Office of Applied Studies, 2001.
  • European Monitoring Centre for Drugs and Drug Addic- tion. Annual report on the state of the drugs problem in the European Union. Brussels: European Monitoring Centre for Drugs and Drug Addiction, 2001.
  • Australian Institute of Health and Welfare. National drug strategy household survey: first results. Canberra: Australian Institute of Health and Welfare, 2001.
  • Swift W, Hall W, Teeson M. Cannabis use disorders among Australian adults: findings from the National Survey of Mental Health and Wellbeing. Sydney: National Drug and Alcohol Research Centre: Sydney, 1999.
  • Hall W, Slowij N, Lemon J. The health and psychological consequences of cannabis use. Canberra: Australian Gov- ernment Publishing Service, 1994.
  • Solowij N. Cannabis and cognitive functioning. New York: Cambridge University Press, 1998.
  • van Os J, Bak M, Hanssen M, Bijl RV, de Graaf R, Verdoux H. Cannabis use and psychosis: a longitudinal population- based study. Am J Epidemiol 2002;156:319–27.
  • Patton GC, Coffey C, Carlin JB, Degenhardt L, Lynskey M, Hall W. Cannabis use and mental health in young people: cohort study. Br Med J 2002;325:1195–8.
  • Childers SR, Breivogel CS. Cannabis and endogenous cannabinoid systems. Drug Alcohol Depend 1998;51:173–87.
  • Gardner EL, Vorel SR. Cannabinoid transmission and reward-related events. Neurobiol Dis 1998;5:502–33.
  • Kandel DB, Chen K. Types of marijuana uses by long- itudinal course. J Stud Alcohol 2000;61:367–78.
  • Becker HS. Becoming a marijuana user. Am J Sociol 1953;59:235–42.
  • Schafer J, Brown SA. Marijuana and cocaine effect expectancies and drug use patterns. J Consult Clin Psychol 1991;59:558–65.
  • Galen LW, Henderson MJ. Validation of cocaine and marijuana effect expectancies in a treatment setting. Addict Behav 1999;24:719–24.
  • Aarons GA, Brown SA, Stice E, Coe MT. Psychometric evaluation of the marijuana and stimulant effect expectancy questionnaires for adolescents. Addict Behav 2001;26:219–36.
  • Mueser KT, Pallavi N, Tracy JI, DeGirolamo J, Molinaro M. Expectations and motives for substance use in schizo- phrenia. Schizophr Bull 1995;21:367–78.
  • Goode E. The marijuana smokers. New York: Basic Books, 1970.
  • Block RI, Erwin WJ, Farinpour R, Braverman K. Sedative, stimulant, and other subjective effects of marijuana: relationships to smoking techniques. Pharmacol Biochem Behav 1998;59:405–12.
  • Jones RT. Marihuana-induced ‘high’: influence of expecta- tion, setting and previous drug experience. Pharmacol Rev 1971;23:359–69.
  • Hollister LE, Overall JE. Dimensions of marihuana experience. Drug Alcohol Depend 1975;1:155–64.
  • Page JB, Carter WE. Smoking environment and effects. In: Carter WE, ed. Cannabis in Costa Rica. Philadelphia: Institute for the Study of Human Issues, 1980:116–44.
  • Reilly D, Didcott P, Swift W, Hall W. Long-term cannabis use: characteristics of users in an Australian rural area. Addiction 1998;93:837–46.
  • Klonoff H, Clark C. Drug patterns in the chronic marijuana user. Int J Addict 1976;11:71–80.
  • Chopra GS. Studies on psycho-clinical aspects of long-term marihuana use in 124 cases. Int J Addict 1973;8:1015–26.
  • Rubin V, Comitas L. Ganja in Jamaica: a medical anthropological study of chronic marihuana use. The Hague: Mouton, 1975.
  • Soueif MI. The use of cannabis in Egypt: a behavioural study. Bull Narc 1971;23:17–28.
  • Noyes Jr R, Brunk SF, Avery DH, Canter A. Psychologic effects of oral delta-9-tetrahydrocannabinol in advanced cancer patients. Compr Psychiatry 1976;17:641–6.
  • Consroe P, Musty R, Rein J, Tillery W, Pertwee R. The perceived effects of smoked cannabis on patients with multiple sclerosis. Eur Neurol 1997;38:44–8.
  • Harris D, Jones RT, Shank R, et al. Self-reported marijuana effects and characteristics of 100 San Francisco Medical Marijuana Club members. J Addict Dis 2000;19:89–103.
  • Sudman S, Bradburn N. Asking questions: a practical guide to questionnaire design. San Francisco: Jossey-Bass, 1982.
  • Schwarz N, Hippler H-J, Noelle-Neumann E. Retrospective reports: the impact of response formats. In: Schwarz N, Sudman S, eds. Autobiographical memory and the validity of retrospective reports. New York: Springer-Verlag, 1994:187–99.
  • Berke J, Hernton C. The cannabis experience: an inter- pretative study of the effects of marijuana and hashish. London: Peter Owen, 1974.
  • Atha M, Blanchard S, Ganley B. Written evidence for the House of Lords Science and Technology Comittee: Sub- Committee I: cannabis. Wigan: Independent Drug Mon- itoring Unit, 1998.
  • Liakos A, Boulougouris J. Subjective experiences of cannabis use in long-term users. In: Stefanis C, Dornbush R, Fink M,eds. Hashish: studies of long term use. New York: Raven Press, 1977:39–42.
  • Davidson ES, Schenk S. Variability in subjective responses to marijuana: initial experiences of college students. Addict Behav 1994;19:531–38.
  • Keeler MH. Motivation for marihuana use: a correlate of adverse reaction. Am J Psychiatry 1968;125:386–90.
  • Tart CT. On being stoned: a psychological study of marijuana intoxication. Palo Alto: Science and Behavior Books, 1971.
  • Traub SH. Perceptions of Marijuana and its effects: a comparison of users and nonusers. Br J Addict 1977;72:67–74.
  • Halikas JA, Goodwin DW, Guze SB. Marihuana effects: a survey of regular users. JAMA 1971;217:692–4.
  • Hendin H, Pollinger Haas A, Singer P, Ellnerer M, Ulman R. Living high: daily marijuana use among adults. New York: Human Sciences Press, 1987.
  • Gruber AJ, Pope Jr HG, Oliva P. Very long term users of marijuana in the United States: a pilot study. Subst Use Misuse 1997;32:249–64.
  • Lyons MJ, Toomey R, Meyer JM, et al. How do genes influence marijuana use? The role of subjective effects. Addiction 1997;92:409–17.
  • Weller RA, Halikas JA. Change in effects from marijuana: a five-to six-year follow-up. J Clin Psychiatry 1982;43:362–5.
  • Zacny JP, Chait LD. Response to marijuana as a function of potency and breathhold duration. Psychopharmacology 1991;103:223–6.
  • Hart CL, van Gorp W, Haney M, Foltin RW, Fischman MW. Effects of acute smoked marijuana on complex cognitive performance. Neuropsychopharmacology 2001;25:757–65.
  • Hart CL, Ward AS, Haney M, Comer SD, Foltin RW, Fischman MW. Comparison of smoked marijuana and oral Δ9-tetrahy Δrocannabinol in humans. Psychopharmacology 2002;164:407–15.
  • Kirk JM, De Wit H, Responses to oral Δ9-tetrahydrocanna- binol in frequent and infrequent marijuana users. Pharma- col Biochem Behav 1999;63:137–42.
  • Haney M, Comer SD, Ward AS, Foltin RW, Fischman MW. Factors influencing marijuana self-administration by humans. Behav Pharmacol 1997;8:101–12.
  • Chait LD, Evans SM, Grant KA, Johanson CE, Schuster CR. Discriminative stimulus and subjective effects of smoked marijuana in humans. Psychopharmacology 1988;94:206–12.
  • Chait LD, Zacny JP. Reinforcing and subjective effects of oral Δ9-THC and smoked marijuana in humans. Psycho- pharmacology 1992; 107:255–62.
  • Chait LD, Perry JL. Acute and residual effects of alcohol and marijuana, alone and in combination, on mood and performance. Psychopharmacology 1994;115:340–9.
  • Waskow IE, Olsson JE, Salzman C, Katz MM, Chase C. Psychological effects of tetrahydrocannabinol. Arch Gen Psychiatry 1970;22:97–107.
  • Lukas SE, Mendelson JH, Benedikt R. Electroencephalo- graphic correlates of marihuana induced euphoria. Drug Alcohol Depend 1995;37:131–40.
  • Lukas SE, Sara O. Ethanol increases plasma Δ9-tetrahy- drocannabinol (THC) levels and subjective effects after marihunana smoking in human volunteers. Drug Alcohol Depend 2001;64:143–9.
  • Heishman SJ, Arasteh K, Stitzer ML. Comparative effects of alcohol and marijuana on mood, memory, and perfor- mance. Pharmacol Biochem Behav 1997;58:93–101.
  • Rossi AM, Babor TF, Meyer RE, Mendelson JH. Mood States. In: Mendelson JH, Rossi AM, Meyer RE, eds. The use of marihuana: a psychological and physiological inquiry. New York: Plenum Press, 1974:115–60.
  • Miller LL, Cocchetto DM, Perez Reyes M. Relationships between several pharmacokinetic parameters and psycho- metric indices of subjective effects of Δ9-tetrahydrocanna- binol in man. Eur J Clin Pharmacol 1983;25:633–37.
  • Kirk JM, Doty P, de Wit H. Effects of expectancies on subjective responses to oral Δ 9 tetrahydrocannabinol. Pharmacol Biochem Behav 1998;59:287–93.
  • Abel EL. Changes in anxiety feelings following marihuana smoking. Br J Addict 1971;66:185–7.
  • Gardner EL. Brain rewards mechanism. In: Lowinson J, Millman R, Langrod J, eds. Substance abuse: a compre- hensive text book. Baltimore: Williams and Wilkins, 1997:51–85.
  • Dahl H, Stengel B. A classification of emotion words: a modification and partial test of de Rivera’s decision theory of emotions. Psychoanal Contemp Thought 1978;1:269–312.
  • Wilmot R. Euphoria. J Drug Issues 1985;15:155–91.
  • Cohen S. The substance abuse problems. Vol. 2: New issues for the 1980s. New York: The Haworth Press, 1985.
  • Compton DR, Dewey WL, Martin BR. Cannabis depen- dence and tolerance production. Adv Alcohol Subst Abuse 1990;9:129–47.
  • Babor TF, Rossi AM, Sagotsky G, Meyer RE. Group behavior: verbal interaction. In: Mendelson JH, Rossi AM, Meyer RE, eds. The use of marihuana: a psychological and physiological inquiry. New York: Plenum Press, 1974:61–72.
  • Georgotas A, Zeidenberg P. Observations on the effects of four weeks of heavy marihuana smoking on group interac- tion and individual behavior. Compr Psychiatry 1979;20:427–32.
  • Higgins ST, Stitzer ML. Acute marijuana effects on social conversation. Psychopharmacology (Berlin) 1986;89:234–38.
  • Hall W, Swift W. The THC content of cannabis in Australia: evidence and implications. Aust NZ J Public Health 2000;24:503–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.